第十一批国采节后开标，将遵循”反内卷”原则

Core Viewpoint - The 11th batch of national drug procurement will open bidding on October 21 in Shanghai, covering 55 varieties and 162 specifications, including key areas such as antiviral drugs and innovative treatments for kidney diseases [1] Group 1: Procurement Details - The procurement includes oral sustained-release forms, inhalants, and topical patches [1] - The procurement plan emphasizes principles of "stabilizing clinical use, ensuring quality, preventing collusion, and countering internal competition" [1] Group 2: Price Control Mechanism - A significant highlight is the optimization of the price control "anchor," which aims to ensure fairness by controlling the price difference for selected bids [1] - The new rules do not solely focus on the lowest bid but establish a rational price range, allowing companies to compete within a reasonable scope [1] - The anchor price is calculated as the higher value between 50% of the average "unit comparable price" of valid applicants and the lowest "unit comparable price" [1]